MB "Dermadenta" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 83,074 |
| 33,230 |
| 17,561 |
| 17,220 |
| 6,888 |
| 94.64 |
| 20.73 |
| 19,912 |
| 4,451 |
| 16,394 |
| 7,852 |
| 0.04 |
| 0.22 |
| - |
| - |
| 21.14 |
| 17,561 |
| 2024 |
|---|
| 94,675 |
| 31,558 |
| 9,939 |
| 9,939 |
| 3,313 |
| 74.60 |
| 10.50 |
| 29,852 |
| 4,152 |
| 16,076 |
| 17,795 |
| 0.14 |
| 0.14 |
| - |
| - |
| 10.50 |
| 9,941 |
| 2025 |
|---|
| 103,372 |
| 34,457 |
| -1,117 |
| -1,117 |
| -372 |
| 60.09 |
| -1.08 |
| 13,735 |
| 2,873 |
| 12,324 |
| 4,151 |
| 0.01 |
| 0.21 |
| - |
| - |
| -1.08 |
| -1,117 |
| 2025 |
|---|
| 103,372 |
| 34,457 |
| -1,117 |
| -1,117 |
| -372 |
| 60.09 |
| -1.08 |
| 13,735 |
| 2,873 |
| 12,324 |
| 4,151 |
| 0.01 |
| 0.21 |
| - |
| - |
| -1.08 |
| -1,117 |
Turnover (€)
2025
Turnover (€)
103,372 €9 % *
Sales per employee (€)
34,457 €9 % *
Profit before tax (€)
-1,117 €-111 % *
Net Profit (€)
-1,117 €-111 % *
Profit per employee (€)
-372 €-111 % *
Total profitability (%)
60.09 %-19.45 % *
Net profitability (%)
-1.08 %-110.29 % *
Equity (€)
13,735 €-54 % *
Amounts Payable And Liabilities (€)
2,873 €-31 % *
Non-current Assets (€)
12,324 €-23 % *
CurrentAssets (€)
4,151 €-77 % *
Working capital requirement
0.01 -92.86 % *
Debt-to-equity ratio
0.21 50.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-1.08 %-110.29 % *
EBIT (€)
-1,117 €-111 % *
